J

Jedd D. Wolchok

Cornell University

ORCID: 0000-0001-6718-2222

Publishes on Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research. 1.4k papers and 208k citations.

PubIndex Score98Top 2%How it's scored

🌟#1 Current Senior Leader in Cancer Immunotherapy and Biomarkers 🌟#7 Current Senior Leader in CAR-T cell therapy research

1.4kPublications

208kTotal Citations

#1in Cancer Immunotherapy and Biomarkers

First publication: 1992First senior author: 2002

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research Melanoma and MAPK Pathways Cutaneous Melanoma Detection and Management

Top publicationsby citations

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein, Ronald P. DeMatteo, Chung‐Han Lee et al.|Nature Genetics|2019

Cited by 4.4k

Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Mario Sznol, Harriet M. Kluger et al.|New England Journal of Medicine|2013

Cited by 4.2k

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

Héctor Peinado, David Lyden, Maša Alečković et al.|Nature Medicine|2012

Cited by 3.7k

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, John A. Thompson, Christina Lacchetti et al.|Journal of Clinical Oncology|2018

Cited by 3.7k

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

James Larkin, Jedd D. Wolchok|New England Journal of Medicine|2019

Cited by 3.7k